Executives worldwide have relied for decades on Clive Reading`s counsel and powerful planning systems. His success in consulting has its roots in a venerable career with such notables as Philip Morris and Ernst & Young, marked by historic product launches, major achievements in productivity, and legendary customer satisfaction.

Focusing his consultancy on pharmaceutical and biotech companies, Clive has continued an impeccable track record with clients such as Pacira Pharmaceuticals, The Medicines Company, Eyetech Pharmaceuticals, Ilex Oncology, Lundbeck, Medsite, Bio‐Imaging, Quintiles Transnational, and Innovex.

He was involved with the first successful biotech IPO in 2004, leading to a market capitalization of $1.8 billion. Another of his clients was acquired for $1 billion. All have enjoyed success in reaching their goals and have improved their competitive position through working with Clive.

He has authored two books, including Strategic Business Planning – A Dynamic System for Improving Performance and Competitive Advantage, and his renowned seminar has been attended by over 700 executives around the world.

“Clive presents an interesting adaptation of traditional strategic planning by focusing on the unique integration of a company`s goals, strategies, performance targets, and action programs into an organization’s culture.”
‐ S. R. Kahn, University of Cincinnati in CHOICE